OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Effects of Confounding Bias in Coronavirus Disease 2019 (COVID-19) and Influenza Vaccine Effectiveness Test-Negative Designs Due to Correlated Influenza and COVID-19 Vaccination Behaviors
Margaret K. Doll, Stacy Pettigrew, Julia Ma, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e564-e571
Open Access | Times Cited: 74
Margaret K. Doll, Stacy Pettigrew, Julia Ma, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e564-e571
Open Access | Times Cited: 74
Showing 1-25 of 74 citing articles:
Early Estimates of Bivalent mRNA Vaccine Effectiveness in Preventing COVID-19–Associated Hospitalization Among Immunocompetent Adults Aged ≥65 Years — IVY Network, 18 States, September 8–November 30, 2022
Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 5152, pp. 1625-1630
Open Access | Times Cited: 106
Diya Surie, Jennifer DeCuir, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2022) Vol. 71, Iss. 5152, pp. 1625-1630
Open Access | Times Cited: 106
Interim Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccines Against COVID-19–Associated Emergency Department and Urgent Care Encounters and Hospitalization Among Immunocompetent Adults Aged ≥18 Years — VISION and IVY Networks, September 2023–January 2024
Jennifer DeCuir, Amanda B. Payne, Wesley H. Self, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 180-188
Open Access | Times Cited: 46
Jennifer DeCuir, Amanda B. Payne, Wesley H. Self, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 180-188
Open Access | Times Cited: 46
Interim Estimates of 2023–24 Seasonal Influenza Vaccine Effectiveness — United States
Aaron M. Frutos, Ashley M. Price, Elizabeth Harker, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 168-174
Open Access | Times Cited: 44
Aaron M. Frutos, Ashley M. Price, Elizabeth Harker, et al.
MMWR Morbidity and Mortality Weekly Report (2024) Vol. 73, Iss. 8, pp. 168-174
Open Access | Times Cited: 44
2023/24 mid-season influenza and Omicron XBB.1.5 vaccine effectiveness estimates from the Canadian Sentinel Practitioner Surveillance Network (SPSN)
Danuta M. Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Eurosurveillance (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 32
Danuta M. Skowronski, Yuping Zhan, Samantha E Kaweski, et al.
Eurosurveillance (2024) Vol. 29, Iss. 7
Open Access | Times Cited: 32
Effectiveness of autumn 2023 COVID-19 vaccination and residual protection of prior doses against hospitalisation in England, estimated using a test-negative case-control study
Freja Kirsebom, Julia Stowe, Jamie Lopez Bernal, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106177-106177
Open Access | Times Cited: 14
Freja Kirsebom, Julia Stowe, Jamie Lopez Bernal, et al.
Journal of Infection (2024) Vol. 89, Iss. 1, pp. 106177-106177
Open Access | Times Cited: 14
Interim estimates of vaccine effectiveness against influenza A(H1N1)pdm09 and A(H3N2) during a delayed influenza season, Canada, 2024/25
Lea Separovic, Yuping Zhan, Samantha E Kaweski, et al.
Eurosurveillance (2025) Vol. 30, Iss. 4
Open Access | Times Cited: 4
Lea Separovic, Yuping Zhan, Samantha E Kaweski, et al.
Eurosurveillance (2025) Vol. 30, Iss. 4
Open Access | Times Cited: 4
Effectiveness of 2023 southern hemisphere influenza vaccines against severe influenza-associated illness: pooled estimates from eight countries using the test-negative design
Radhika Gharpure, Annette K. Regan, Francisco Nogareda, et al.
The Lancet Global Health (2025) Vol. 13, Iss. 2, pp. e203-e211
Closed Access | Times Cited: 1
Radhika Gharpure, Annette K. Regan, Francisco Nogareda, et al.
The Lancet Global Health (2025) Vol. 13, Iss. 2, pp. e203-e211
Closed Access | Times Cited: 1
Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021–2022 Influenza Season
Ashley M Price, Brendan Flannery, H. Keipp Talbot, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1358-1363
Open Access | Times Cited: 37
Ashley M Price, Brendan Flannery, H. Keipp Talbot, et al.
Clinical Infectious Diseases (2022) Vol. 76, Iss. 8, pp. 1358-1363
Open Access | Times Cited: 37
Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23
Danuta M. Skowronski, Erica Chuang, Suzana Sabaiduc, et al.
Eurosurveillance (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 36
Danuta M. Skowronski, Erica Chuang, Suzana Sabaiduc, et al.
Eurosurveillance (2023) Vol. 28, Iss. 5
Open Access | Times Cited: 36
Effectiveness of Monovalent mRNA COVID-19 Vaccination in Preventing COVID-19–Associated Invasive Mechanical Ventilation and Death Among Immunocompetent Adults During the Omicron Variant Period — IVY Network, 19 U.S. States, February 1, 2022–January 31, 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 17, pp. 463-468
Open Access | Times Cited: 32
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 17, pp. 463-468
Open Access | Times Cited: 32
Influenza vaccine effectiveness in Europe: Results from the 2022–2023 VEBIS (Vaccine Effectiveness, Burden and Impact Studies) primary care multicentre study
Marine Maurel, Francisco Pozo, Gloria Pérez‐Gimeno, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Marine Maurel, Francisco Pozo, Gloria Pérez‐Gimeno, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 11
Effectiveness of Updated 2023–2024 (Monovalent XBB.1.5) COVID-19 Vaccination Against SARS-CoV-2 Omicron XBB and BA.2.86/JN.1 Lineage Hospitalization and a Comparison of Clinical Severity—IVY Network, 26 Hospitals, October 18, 2023–March 9, 2024
C. Kevin, Diya Surie, Adam S. Lauring, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 10
C. Kevin, Diya Surie, Adam S. Lauring, et al.
Clinical Infectious Diseases (2024)
Open Access | Times Cited: 10
Effectiveness of COVID-19 vaccines administered in the 2023 autumnal campaigns in Europe: Results from the VEBIS primary care test-negative design study, September 2023–January 2024
Charlotte Lanièce Delaunay, Aryse Martins Melo, Marine Maurel, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. 3931-3937
Open Access | Times Cited: 7
Charlotte Lanièce Delaunay, Aryse Martins Melo, Marine Maurel, et al.
Vaccine (2024) Vol. 42, Iss. 19, pp. 3931-3937
Open Access | Times Cited: 7
Influenza vaccine effectiveness against influenza A subtypes in Europe: Results from the 2021–2022 I‐MOVE primary care multicentre study
Esther Kissling, Francisco Pozo, Iván Martínez‐Baz, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Esther Kissling, Francisco Pozo, Iván Martínez‐Baz, et al.
Influenza and Other Respiratory Viruses (2022) Vol. 17, Iss. 1
Open Access | Times Cited: 31
Observed negative vaccine effectiveness could be the canary in the coal mine for biases in observational COVID-19 studies
Korryn Bodner, Michael A. Irvine, Jeffrey C. Kwong, et al.
International Journal of Infectious Diseases (2023) Vol. 131, pp. 111-114
Open Access | Times Cited: 18
Korryn Bodner, Michael A. Irvine, Jeffrey C. Kwong, et al.
International Journal of Infectious Diseases (2023) Vol. 131, pp. 111-114
Open Access | Times Cited: 18
COVID-19 vaccine effectiveness against symptomatic infection with SARS-CoV-2 BA.1/BA.2 lineages among adults and adolescents in a multicentre primary care study, Europe, December 2021 to June 2022
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Charlotte Lanièce Delaunay, Iván Martínez‐Baz, Noémie Sève, et al.
Eurosurveillance (2024) Vol. 29, Iss. 13
Open Access | Times Cited: 6
Interim 2023/2024 Season Influenza Vaccine Effectiveness in Primary and Secondary Care in the United Kingdom
Heather Whitaker, Beth Findlay, Jana Zitha, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 6
Heather Whitaker, Beth Findlay, Jana Zitha, et al.
Influenza and Other Respiratory Viruses (2024) Vol. 18, Iss. 5
Open Access | Times Cited: 6
A framework for monitoring RSV prevention product effectiveness in the United States
Lauren E. Roper, Ruth Link‐Gelles, Diya Surie, et al.
Vaccine (2025) Vol. 45, pp. 126633-126633
Closed Access
Lauren E. Roper, Ruth Link‐Gelles, Diya Surie, et al.
Vaccine (2025) Vol. 45, pp. 126633-126633
Closed Access
Interim Estimates of 2024–2025 Seasonal Influenza Vaccine Effectiveness — Four Vaccine Effectiveness Networks, United States, October 2024–February 2025
Aaron M. Frutos, Seana Cleary, Emily Reeves, et al.
MMWR Morbidity and Mortality Weekly Report (2025) Vol. 74, Iss. 6, pp. 83-90
Open Access
Aaron M. Frutos, Seana Cleary, Emily Reeves, et al.
MMWR Morbidity and Mortality Weekly Report (2025) Vol. 74, Iss. 6, pp. 83-90
Open Access
Vaccine Effectiveness Against Influenza-Associated Urgent Care, Emergency Department, and Hospital Encounters During the 2021–2022 Season, VISION Network
Mark W. Tenforde, Zachary A. Weber, Malini B. DeSilva, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 185-195
Open Access | Times Cited: 15
Mark W. Tenforde, Zachary A. Weber, Malini B. DeSilva, et al.
The Journal of Infectious Diseases (2023) Vol. 228, Iss. 2, pp. 185-195
Open Access | Times Cited: 15
Vaccine Effectiveness Against Influenza A–Associated Hospitalization, Organ Failure, and Death: United States, 2022–2023
Nathaniel M. Lewis, Yuwei Zhu, Ithan D. Peltan, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 1056-1064
Open Access | Times Cited: 15
Nathaniel M. Lewis, Yuwei Zhu, Ithan D. Peltan, et al.
Clinical Infectious Diseases (2023) Vol. 78, Iss. 4, pp. 1056-1064
Open Access | Times Cited: 15
Influenza Vaccine Effectiveness Against Influenza A–Associated Emergency Department, Urgent Care, and Hospitalization Encounters Among US Adults, 2022–2023
Mark W. Tenforde, Zachary A. Weber, Duck‐Hye Yang, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. 141-151
Open Access | Times Cited: 12
Mark W. Tenforde, Zachary A. Weber, Duck‐Hye Yang, et al.
The Journal of Infectious Diseases (2023) Vol. 230, Iss. 1, pp. 141-151
Open Access | Times Cited: 12
Durability of protection from original monovalent and bivalent COVID-19 vaccines against COVID-19-associated hospitalization and severe in-hospital outcomes among adults in the United States — September 2022–August 2023
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Jennifer DeCuir, Diya Surie, Yuwei Zhu, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Influenza vaccine effectiveness against A(H3N2) during the delayed 2021/22 epidemic in Canada
Shin Hye Kim, Erica Chuang, Suzana Sabaiduc, et al.
Eurosurveillance (2022) Vol. 27, Iss. 38
Open Access | Times Cited: 19
Shin Hye Kim, Erica Chuang, Suzana Sabaiduc, et al.
Eurosurveillance (2022) Vol. 27, Iss. 38
Open Access | Times Cited: 19
Interim Effectiveness Estimates of 2023 Southern Hemisphere Influenza Vaccines in Preventing Influenza-Associated Hospitalizations — REVELAC–i Network, March–July 2023
Ashley Fowlkes, Francisco Nogareda, Annette K. Regan, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 37, pp. 1010-1015
Open Access | Times Cited: 12
Ashley Fowlkes, Francisco Nogareda, Annette K. Regan, et al.
MMWR Morbidity and Mortality Weekly Report (2023) Vol. 72, Iss. 37, pp. 1010-1015
Open Access | Times Cited: 12
